Back to top
more

Anthem, Inc. (ANTM)

(Delayed Data from NYSE)

$261.70 USD

261.70
1,184,666

+0.11 (0.04%)

Updated May 3, 2019 04:00 PM ET

After-Market: $261.69 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Based in Indianapolis, IN, and formed through the merger of Anthem Inc. and WellPoint Health Networks Inc. in Nov 2004, Anthem Inc. is one of the largest publicly traded managed care organizations in terms of membership. The company was previously named WellPoint Inc. (WLP). The company is also an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Anthem is the largest BCBS plan provider in the United States. As of Mar 31, 2020, it catered to 42.1 million medical members through its affiliated health plans.

Anthem (ANTM) Q1 Earnings Beat Estimates

by Zacks Equity Research

Anthem (ANTM) delivered earnings and revenue surprises of 2.19% and -3.42%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

UnitedHealth (UNH) to Help Eligible Medicaid Members in Ohio

by Zacks Equity Research

UnitedHealth (UNH) intends to improve health outcomes of eligible Medicaid members in Ohio where it already boasts a strong presence.

Why Anthem (ANTM) Might Surprise This Earnings Season

by Zacks Equity Research

Anthem (ANTM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Anthem (ANTM) to Report Q1 Earnings: What's in its Store?

by Zacks Equity Research

Anthem's (ANTM) first-quarter earnings to reflect better revenues and higher membership.

UnitedHealth (UNH) Beats on Q1 Earnings, Revises '21 Guidance

by Zacks Equity Research

UnitedHealth's (UNH) first-quarter 2021 earnings grow on the back of increased revenues.

Anthem (ANTM) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Anthem (ANTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UnitedHealth (UNH) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research

UnitedHealth's (UNH) first-quarter results are likely to reflect well-performing UnitedHealthcare and Optum businesses, partly offset by elevated expenses related to COVID-19 pandemic.

Cigna (CI), Oscar to Aid Small Business With Health Insurance

by Zacks Equity Research

Cigna (CI) along with Oscar Health rolls out a health insurance product aimed for small business units in the state of California.

UnitedHealth (UNH) to Aid Eligible Medicaid Members in Hawaii

by Zacks Equity Research

UnitedHealth (UNH) to improve health outcomes of Medicaid members in Hawaii through contract wins.

Here's Why You Should Stay Away From Anthem (ANTM) Right Now

by Zacks Equity Research

Anthem's (ANTM) weak balance sheet and steep expenses will likely keep the stock stressed.

Here's Why Hold Strategy is Apt for Centene (CNC) Stock

by Zacks Equity Research

Riding on its inorganic growth story and 2021 guidance, Centene (CNC) holds enough potential to reap benefits for investors.

Sheraz Mian headshot

Top Stock Reports for UnitedHealth, Sony & American Tower

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), Sony (SNE), and American Tower (AMT).

Anthem (ANTM) to Buy myNEXUS to Boost Homehealth Business

by Zacks Equity Research

Anthem (ANTM) to purchase at-home provider, benefits coordinator, myNEXUS, to provide better in-home care.

UnitedHealthcare (UNH) Expands Virtual Care to Hearing Aids

by Zacks Equity Research

UnitedHealthcare's (UNH) new virtual care model Right2You aims to provide its members with an online service for custom-programed hearing aids.

Centene (CNC) vs. Humana (HUM): Which is Better-Positioned?

by Zacks Equity Research

Centene (CNC) and Humana (HUM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which stock is more profitable based on fundamentals.

UnitedHealth (UNH) Invests in Technology to Lead the Industry

by Zacks Equity Research

The breakout of COVID-19 fuels the use of technology in the healthcare space and UnitedHealth (UNH) is promptly acting on this to ramp up its technological innovations.

Anthem (ANTM) Down 0.1% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Workday (WDAY) Q4 Earnings Surpass Estimates, Stock Down

by Zacks Equity Research

Workday's (WDAY) fiscal fourth-quarter results benefit from a high demand for its cloud-based HCM and FINS plus solutions, and synergies from the Scout RFP acquisition.

Centene's (CNC) Hawaii Arm to Keep Offering Healthcare Services

by Zacks Equity Research

Centene's (CNC) Hawaii subsidiary 'Ohana Health Plan is selected to continue catering services via the CSS plan.

Molina Healthcare (MOH) Posts Q4 Loss, Misses on Revenues

by Zacks Equity Research

Molina Healthcare's (MOH) fourth-quarter results reflect escalating expenses.

Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

Tenet Healthcare's (THC) Q4 earnings improve on the back of better revenues.

Centene (CNC) Q4 Earnings Surpass Estimates, Tumble Y/Y

by Zacks Equity Research

Centene (CNC) Q4 results gain from improved revenues as well as better membership.

Cigna (CI) Q4 Earnings Miss, Decline Y/Y on Elevated Claims

by Zacks Equity Research

Cigna's (CI) Q4 results reflect higher revenues, partly offset by an increase in COVID-related claims that eroded its bottom line.

Ensign Group's (ENSG) Q4 Earnings Top Estimates, Improve Y/Y

by Zacks Equity Research

Ensign Group's (ENSG) fourth-quarter results reflect a year-over-year rise in revenues.

Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y

by Zacks Equity Research

Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.